Authors: Heald, A Selby, PL White, A Gibson, JM

Citation: A. Heald et al., Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis, AM J OBST G, 183(3), 2000, pp. 593-600

Authors: van Niel, MB Beer, MS Castro, JL Cheng, SKF Evans, DC Heald, A Hitzel, L Hunt, P Mortishire-Smith, R O'Connor, D Watt, AP MacLeod, AM

Citation: Mb. Van Niel et al., Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1A and 5-HT re-uptake ligands, BIOORG MED, 9(22), 1999, pp. 3243-3248

Authors: Sternfeld, F Guiblin, AR Jelley, RA Matassa, VG Reeve, AJ Hunt, PA Beer, MS Heald, A Stanton, JA Sohal, B Watt, AP Street, LJ

Citation: F. Sternfeld et al., Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: Potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor, J MED CHEM, 42(4), 1999, pp. 677-690

Authors: van Niel, MB Collins, I Beer, MS Broughton, HB Cheng, SKF Goodacre, SC Heald, A Locker, KL MacLeod, AM Morrison, D Moyes, CR O'Connor, D Pike, A Rowley, M Russell, MGN Moyes, CR O'Connor, D Pike, A Rowley, M Russell, MGN Sohal, B Stanton, JA Thomas, S Verrier, H Watt, AP Castro, JL

Citation: Mb. Van Niel et al., Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles, J MED CHEM, 42(12), 1999, pp. 2087-2104